{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T03:48:46Z","timestamp":1774928926200,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,12,18]],"date-time":"2011-12-18T00:00:00Z","timestamp":1324166400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s00432-011-1113-y","type":"journal-article","created":{"date-parts":[[2011,12,17]],"date-time":"2011-12-17T14:59:07Z","timestamp":1324133947000},"page":"439-449","source":"Crossref","is-referenced-by-count":7,"title":["RUNX3 is involved in caspase-3-dependent apoptosis induced by a combination of 5-aza-CdR and TSA in leukaemia cell lines"],"prefix":"10.1007","volume":"138","author":[{"given":"Feng-Xian","family":"Zhai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-Fu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui-Fang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi-Jie","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Gang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Jiang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Jun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,12,18]]},"reference":[{"key":"1113_CR1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/mc.10159","volume":"38","author":"X Agirre","year":"2003","unstructured":"Agirre X, Novo FJ, Calasanz MJ et al (2003a) TP53 is frequently altered by methylation, mutation, and\/or deletion in acute lymphoblastic leukaemia. Mol Carcinog 38:201\u2013208","journal-title":"Mol Carcinog"},{"key":"1113_CR2","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/sj.onc.1206236","volume":"22","author":"X Agirre","year":"2003","unstructured":"Agirre X, Vizmanos JL, Calasanz MJ et al (2003b) Methylation of CpG dinucleotides and\/or CCWGG motifs at the promoter of TP53 correlates with decreased gene expression in a subset of acute lymphoblastic leukemia patients. Oncogene 22:1070\u20131072","journal-title":"Oncogene"},{"key":"1113_CR3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0378-1119(95)00060-J","volume":"159","author":"SC Bae","year":"1995","unstructured":"Bae SC, Takahashi E, Zhang YW, Ogawa E, Shigesada K, Namba Y, Satake M, Ito Y (1995) Cloning, mapping and expression of PEBP2 alpha C, a third gene encoding the mammalian Runt domain. Gene 159:245\u2013248","journal-title":"Gene"},{"key":"1113_CR4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/417235a","volume":"417","author":"A Balmain","year":"2002","unstructured":"Balmain A (2002) Cancer: new-age tumor suppressors. Nature 417:235\u2013237","journal-title":"Nature"},{"key":"1113_CR5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0378-1119(01)00760-0","volume":"279","author":"C Bangsow","year":"2001","unstructured":"Bangsow C, Rubins N, Glusman G et al (2001) The RUNX3 gene-sequence structure and regulated expression. Gene 279:221\u2013232","journal-title":"Gene"},{"key":"1113_CR6","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1126\/science.281.5383.1674","volume":"281","author":"S Banin","year":"1998","unstructured":"Banin S, Moyal L, Shieh S et al (1998) Enhanced phosphorylation of P53 by ATM in response to DNA damage. Science 281:1674\u20131677","journal-title":"Science"},{"key":"1113_CR7","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0168-9525(99)01971-X","volume":"16","author":"SB Baylin","year":"2000","unstructured":"Baylin SB, Herman JG (2000) DNA hypermethylation in tumorigenesis. Trends Genet 16:168\u2013174","journal-title":"Trends Genet"},{"key":"1113_CR8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1101\/gad.947102","volume":"16","author":"A Bird","year":"2002","unstructured":"Bird A (2002) DNA methylation patterns and epigenetic memory. Genes Dev 16:6\u201321","journal-title":"Genes Dev"},{"key":"1113_CR9","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0092-8674(00)81532-9","volume":"99","author":"AP Bird","year":"1999","unstructured":"Bird AP, Wolffe AP (1999) Methylation-induced repression belts, braces, and chromatin. Cell 99:451\u2013454","journal-title":"Cell"},{"key":"1113_CR10","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1182\/blood-2008-02-137083","volume":"112","author":"KC Chi","year":"2008","unstructured":"Chi KC, Margaret HLN (2008) Transcriptional repression of the gene RUNX3\/AML2 by the t (8:21) and inv (16) fusion proteins in acute myeloid leukemia. Blood 112:3391\u20133402","journal-title":"Blood"},{"key":"1113_CR11","doi-asserted-by":"crossref","first-page":"8097","DOI":"10.1128\/MCB.25.18.8097-8107.2005","volume":"25","author":"XZ Chi","year":"2005","unstructured":"Chi XZ, Yang JO, Kim WJ, Ito Y, Bae SC (2005) RUNX3 suppresses gastric epithelial cell growth by inducing P21WAP1\/Cip1 expression in cooperation with TGF-\u03b2-activated SMAD. Mol Cell Biol 25:8097\u20138107","journal-title":"Mol Cell Biol"},{"key":"1113_CR12","doi-asserted-by":"crossref","first-page":"6489","DOI":"10.1038\/sj.onc.1206814","volume":"22","author":"R Claus","year":"2003","unstructured":"Claus R, Lubbert M (2003) Epigenetic targets in hematopoietic malignancies. Oncogene 22:6489\u20136496","journal-title":"Oncogene"},{"key":"1113_CR13","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1126\/science.1135961","volume":"315","author":"M Cordenonsi","year":"2007","unstructured":"Cordenonsi M et al (2007) Phosphorylation integration of TGF-\u00df and Ras\/MAPK signaling through P53. Science 315:840\u2013843","journal-title":"Science"},{"key":"1113_CR14","first-page":"4243","volume":"6","author":"PG Corn","year":"2000","unstructured":"Corn PG, Smith BD, Ruckdeschel ES, Douglas D, Baylin SB, Herman JG (2000) E-cadherin expression is silenced by 5CpG island methylation in acute leukemia. Clin Cancer Res 6:4243\u20134248","journal-title":"Clin Cancer Res"},{"key":"1113_CR15","doi-asserted-by":"crossref","first-page":"4594","DOI":"10.1073\/pnas.0604716104","volume":"104","author":"M Cornelius","year":"2007","unstructured":"Cornelius M, Rebekka G, Claudia M et al (2007) Retroviral insertional mutagenesis identifies RUNX genes involved in chronic myeloid leukemia disease persistence under imatinib treatment. PNAS 104:4594\u20134599","journal-title":"PNAS"},{"key":"1113_CR16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/jcb.20532","volume":"96","author":"M Dokmanovic","year":"2005","unstructured":"Dokmanovic M, Marks PA (2005) Prospects: histone deacetylase inhibitors. J Cell Biochem 96:293\u2013304","journal-title":"J Cell Biochem"},{"key":"1113_CR17","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nature02625","volume":"429","author":"G Egger","year":"2004","unstructured":"Egger G, Liang G, Aparicio A, Jones PA (2004) Epigenetics in human disease and prospects for epigenetic therapy. Nature 429:457\u2013463","journal-title":"Nature"},{"key":"1113_CR18","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0092-8674(93)90500-P","volume":"75","author":"WS el-Deiry","year":"1993","unstructured":"el-Deiry WS, Tokino T, Velculescu VE et al (1993) WAF1, a potential mediator of P53 tumor suppression. Cell 75:817\u2013825","journal-title":"Cell"},{"key":"1113_CR19","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S1521-6616(03)00208-0","volume":"109","author":"M Esteller","year":"2003","unstructured":"Esteller M (2003) Profiling aberrant DNA methylation in hematologicneoplasms: a view from the tip of the iceberg. Clin Immunol 109:80\u201388","journal-title":"Clin Immunol"},{"key":"1113_CR20","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0022-2836(87)90689-9","volume":"196","author":"M Gardiner-Garden","year":"1987","unstructured":"Gardiner-Garden M, Frommer M (1987) CpG islands in vertebrate genomes. J Mol Biol 196:261\u2013282","journal-title":"J Mol Biol"},{"key":"1113_CR21","doi-asserted-by":"crossref","first-page":"31577","DOI":"10.1074\/jbc.274.44.31577","volume":"274","author":"J Hanai","year":"1999","unstructured":"Hanai J, Chen LF, Kanno T, Ohtani-Fujita N, Kim WY, Guo WH, Imamura T, Ishidou Y, Fukuchi M, Shi MJ, Ito Y (1999) Interaction and functional cooperation of PEBP2\/CBF with Smads. Synergistic induction of the immunoglobulin germline Cpromoter. J Biol Chem 274:31577\u201331582","journal-title":"J Biol Chem"},{"key":"1113_CR22","doi-asserted-by":"crossref","first-page":"37754","DOI":"10.1074\/jbc.M104073200","volume":"276","author":"CA Harris","year":"2001","unstructured":"Harris CA, Eugane MJ (2001) BH3-only Bcl-2 family members are coordinately regulated by the JNK pathway and require Bax to induce apoptosis in neurons. J Biol Chem 276:37754\u201337760","journal-title":"J Biol Chem"},{"key":"1113_CR23","first-page":"722","volume":"56","author":"JG Herman","year":"1996","unstructured":"Herman JG, Jen J, Merlo A, Baylin SB (1996) Hypermethylation-associated inactivation indicates a tumor suppressor role for p15 (INK4B). Cancer Res 56:722\u2013727","journal-title":"Cancer Res"},{"key":"1113_CR24","first-page":"837","volume":"57","author":"JG Herman","year":"1997","unstructured":"Herman JG, Civin CI, Issa JP, Collector MI, Sharkis SJ, Baylin SB (1997) Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies. Cancer Res 57:837\u2013841","journal-title":"Cancer Res"},{"key":"1113_CR25","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0092-8674(00)00187-2","volume":"103","author":"DC Huang","year":"2000","unstructured":"Huang DC, Strasser A (2000) BH3-only proteins\u2014essential initiators of apoptotic cell death. Cell 103:839\u2013842","journal-title":"Cell"},{"key":"1113_CR26","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/nn925","volume":"5","author":"K Inoue","year":"2002","unstructured":"Inoue K, Ozaki S, Shiga T, Ito K, Masuda T, Okado N, Iseda T, Kudo N, Ito Y (2002) RUNX3 controls the axonal projection of proprioceptive dorsal root ganglion neurons. Nat Neurosci 5:946\u2013954","journal-title":"Nat Neurosci"},{"key":"1113_CR27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0959-437X(03)00007-8","volume":"13","author":"Y Ito","year":"2003","unstructured":"Ito Y, Miyazono K (2003) RUNX transcription factors as key targets of TGF-\u03b2 superfamily signaling. Curr Opin Genet Dev 13:43\u201347","journal-title":"Curr Opin Genet Dev"},{"key":"1113_CR28","doi-asserted-by":"crossref","first-page":"7743","DOI":"10.1158\/0008-5472.CAN-05-0743","volume":"65","author":"K Ito","year":"2005","unstructured":"Ito K, Liu Q, Salto-Tellez M, Yano T, Tada K, Ida H, Huang C, Shah N, Inoue M, Yeoh KG, Ito Y (2005) RUNX3, a novel tumor suppressor, is highly inactivated in gastric cancer by protein mislocalization. Cancer Res 65:7743\u20137750","journal-title":"Cancer Res"},{"key":"1113_CR29","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/S0006-291X(82)80067-3","volume":"108","author":"S Jahangeer","year":"1982","unstructured":"Jahangeer S, Elliott RM, Henneberry RC (1982) \u03b2-Adrenergic receptor induction in HeLa cells: synergistic effect of 5-azacytidine and butyrate. Biochem Biophys Res Commun 108:1434\u20131440","journal-title":"Biochem Biophys Res Commun"},{"key":"1113_CR30","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ccr.2008.08.004","volume":"14","author":"I Kosei","year":"2008","unstructured":"Kosei I, Anthony C-BL, Manuel S-T et al (2008) RUNX3 attenuates \u03b2-catenin\/T cell factors in intestinal tumorigenesis. Cancer Cell 14:226\u2013237","journal-title":"Cancer Cell"},{"key":"1113_CR31","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1038\/sj.onc.1205322","volume":"21","author":"U Krug","year":"2002","unstructured":"Krug U, Ganser A, Koeffler HP (2002) Tumor suppressor genes in normal and malignant hematopoiesis. Oncogene 21:3475\u20133495","journal-title":"Oncogene"},{"key":"1113_CR32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0092-8674(02)00690-6","volume":"109","author":"QL Li","year":"2002","unstructured":"Li QL, Ito K, Sakakura C et al (2002) Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 109:113\u2013124","journal-title":"Cell"},{"key":"1113_CR33","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc1779","volume":"6","author":"S Minucci","year":"2006","unstructured":"Minucci S, Pelicci PG (2006) Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat Rev Cancer 6:38\u201351","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"1113_CR35","first-page":"3","volume":"21","author":"V Mudit","year":"2009","unstructured":"Mudit V, Joanna F (2009) Surfactant protein DNA methylation: a new entrant in the field of lung cancer diagnostics? Oncol Rep 21(1):3\u201321","journal-title":"Oncol Rep"},{"key":"1113_CR36","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1242\/jcs.114.3.463","volume":"114","author":"JA Nickerson","year":"2001","unstructured":"Nickerson JA (2001) Experimental observations of a nuclear matrix. J Cell Sci 114:463\u2013474","journal-title":"J Cell Sci"},{"key":"1113_CR37","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/sj.onc.1205112","volume":"21","author":"AL Okorokov","year":"2002","unstructured":"Okorokov AL, Rubbi CP, Metcalfe S, Milner J (2002) The interaction of P53 with the nuclear matrix is mediated by F-actin and modulated by DNA damage. Oncogene 21:356\u2013367","journal-title":"Oncogene"},{"key":"1113_CR38","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/jcb.20813","volume":"98","author":"A Puig-Kroger","year":"2006","unstructured":"Puig-Kroger A, Corbi A (2006) RUNX3: a new player in myeloid gene expression and immune response. J Cell Biochem 98:744\u2013756","journal-title":"J Cell Biochem"},{"key":"1113_CR39","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1182\/blood.V91.8.2985.2985_2985_2990","volume":"91","author":"B Quesnel","year":"1998","unstructured":"Quesnel B, Guillerm G, Vereecque R et al (1998) Methylation of the p15 (INK4b) gene in myelodysplastic syndromes is frequent and acquired during disease progression. Blood 91:2985\u20132990","journal-title":"Blood"},{"key":"1113_CR40","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/jcp.21630","volume":"218","author":"P Sandhya","year":"2009","unstructured":"Sandhya P, Syed AA, Christopher D (2009) Subnuclear targeting of the RUNX3 tumor suppressor and its epigenetic association with mitotic chromosomes. J Cell Physiol 218:473\u2013479","journal-title":"J Cell Physiol"},{"key":"1113_CR41","first-page":"235","volume":"3","author":"D Takai","year":"2003","unstructured":"Takai D, Jones PA (2003) The CpG island searcher: a new WWW resource. In SilicoBiol 3:235\u2013240","journal-title":"In SilicoBiol"},{"key":"1113_CR42","doi-asserted-by":"crossref","first-page":"4809","DOI":"10.1158\/0008-5472.CAN-04-3741","volume":"65","author":"D Wei","year":"2005","unstructured":"Wei D, Gong W, Oh SC et al (2005) Loss of RUNX3 expression significantly affects the clinical outcome of gastric cancer patients and its restoration causes drastic suppression of tumor growth and metastasis. Cancer Res 65:4809\u20134816","journal-title":"Cancer Res"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-011-1113-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-011-1113-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-011-1113-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T23:21:52Z","timestamp":1640042512000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-011-1113-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,18]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["1113"],"URL":"https:\/\/doi.org\/10.1007\/s00432-011-1113-y","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,18]]}}}